NCT04774237View on ClinicalTrials.gov

Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 24, 2021

Primary Completion Date

October 19, 2021

Study Completion Date

October 19, 2021

Conditions
Presbyopia
Interventions
DRUG

BRIMOCHOL™

A single drop in each eye at a visit.

DRUG

BRIMOCHOL™ F

A single drop in each eye at a visit.

DRUG

Carbachol

A single drop in each eye at a visit.

Trial Locations (3)

38119

Total Eye Care, PA, Memphis

91204

Global Research Management, Inc., Glendale

92663

Eye Research Foundation, Newport Beach

Sponsors

Lead Sponsor

Visus Therapeutics
All Listed Sponsors
lead

Visus Therapeutics

OTHER

NCT04774237 - Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia | Biotech Hunter | Biotech Hunter